Big pharma ran millions of dollars of negative ad against me US-during election campaign, says Trump

US President Donald Trump on Friday alleged that big pharma companies ran millions of dollars of negative vertisement against him during just concluded presidential elections.

American media has declared Democratic presidential candidate Joe Biden as winner of vember 3 elections, which Trump has refused to concede. Biden was declared winner of presidential election on vember 7 after flipping Pennsylvania, Michigan and Wisconsin to Democrats' column.

“Big pharma ran millions of dollars of negative vertisements against me during campaign which I won by way but you kw we will find that out, almost 74 million votes,” Trump told reporters at White House, making his first appearance in days.

President-elect Biden has secured 306 electoral votes as compared to Trump's 232 votes. To win race to White House, successful candidate should have at least 270 electoral votes out of 538-member Electoral College.

Trump has refused to concede vember 3 US election results and has filed multiple lawsuits challenging poll results in several states.

“We h big pharma against us, we h media against us, we h a big tech against us. We h a lot of dishonesty against us, but big pharma companies alone ran millions and millions of dollars in s, in fact, I looked at it I said who is it fair --I have never seen anything quite like it because I told m I am going to have to do this,” US President told reporters at White House wherein he also anunced rules to lower price of prescription drugs for American people.

He, however, did t take any questions.

“ unprecedented reforms we are completing today are direct result of historic drug pricing executive orders I signed in July. Statutorily we h to go through a very long process and we got it done. I was very proud to have got this done. We were pushing it very hard as we did with vaccines and or things,” Trump asserted.

first action will save American seniors billions of dollars by preventing middlemen from ripping off Medicare patients with high prescription prices. Currently, drug companies provide large discounts on price of prescription medicines, including nearly USD 40 billion in rebates to Medicare part D plans… often middlemen stop those discounts from going to patients, he ted.

“So, patients are going to be w getting benefits… Patients pay very high prices and although we brought it down first time in 51 years with cost ding up to hundreds or even thousands of dollars per year per patient. Two days action ends this injustice and requires that se discounts go directly to people,” president said.

“This will save patients up to 30, 40 or 50 per cent, could be much higher than that. se are numbers that body has ever even contemplated and that does t include life-saving drugs like insulin which will be even higher,” he ded.

In a statement, PhRMA president and CEO Stephen J Ubl opposed such a move by White House.

“It defies logic that ministration is blindly proceeding with a ‘most favoured nation’ policy that gives foreign governments upper hand in deciding value of medicines in United States. History proves that when governments take unilateral action to set prices, it disrupts patient access to treatments, discours investment in new medicines and threatens jobs and ecomic growth,” he said.

Ubi said PhRMA is considering all options to stop this unlawful onslaught on medical progress and maintain ir ability to win fight against COVID-19.

“As part of 2020 election, Americans me it clear: Policymakers must dress COVID-19 and concerns around pre-existing conditions and out-of-pocket costs,” he said.

Congressman Lloyd Doggett, Chairman of House Ways & Means Health Subcommittee, said anuncement offers little more relief from soaring prescription prices than Trump’s September anuncement of USD 200 drug cards, which he never delivered.

“By delaying, until end of his presidency, taking action he could have undertaken at beginning, Trump offers an invitation to legal challenges-t a guarantee of relief from price gouging. And most important order remains missing: lower prices for drugs developed with taxpayer dollars, including COVID-19 treatments and vaccines,” he said.

(Im: AP)